文献速递妇幼与学校卫生卫生政策与健康促进传染病防控与疫情报告

寨卡避孕可及网络:2016-17年寨卡病毒暴发期间波多黎各增加避孕可及性的可行性规划

The Zika Contraception Access Network: a feasibility programme to increase access to contraception in Puerto Rico during the 2016-17 Zika virus outbreak.
PubMed 文献 · Lancet Public Health · 2018-01-19

寨卡避孕可及网络(Z-CAN)是在2016-17年寨卡暴发期间于波多黎各建立的可行性规划,通过培训153名提供者,向21124名女性免费提供以客户为中心的避孕咨询和全部可逆避孕方法。2016年5月4日至2017年8月15日期间,20110名(95%)女性当日获得可逆避孕方法,14259名(68%)选择并接受了长效可逆避孕方法。

要点

  • Z-CAN通过联邦机构、领地卫生机构、私营企业及慈善组织合作,免费提供可逆避孕方法。
  • 153名提供者服务21124名女性,20110名(95%)当日获得可逆避孕方法。
  • 14259名(68%)女性首次就诊即选择并接受长效可逆避孕方法。

核心结论

  • Z-CAN是为在波多黎各复杂紧急情况下快速实施可逆避孕服务而设计的短期响应,已服务超过21000名女性。
  • 作者认为该模式可作为未来应急准备和响应工作的一部分进行复制或调整。

研究设计与样本

  • Z-CAN为可行性规划,通过建立联邦机构、领地卫生机构、私营企业及慈善和非营利组织之间的伙伴关系开发。
  • 对项目提供者和参与者的描述性特征进行记录,并估计了选择及接受长效可逆避孕方法的相关因素。
  • 参与者被邀请完成患者满意度调查,内容包括是否在全面咨询后当日免费获得所选避孕方法、对护理质量的感知及对所选方法和服务的满意度。

主要发现

  • 2016年5月4日至2017年8月15日期间,Z-CAN规划的153名提供者为21124名女性提供了服务。
  • 20110名(95%)女性当日获得可逆避孕方法。
  • 仅767名(4%)女性在Z-CAN之前使用过长效可逆避孕方法,而14259名(68%)女性在首次就诊时选择并接受了长效可逆避孕方法。
  • 在接受长效可逆避孕方法的女性中,10808名(76%)在Z-CAN就诊前未使用任何方法或使用最低效避孕方法(即安全套或体外射精)。
  • 在参与患者满意度调查的3489名女性中,3294名中的3068名(93%)对所受服务非常满意,3478名中的3216名(93%)报告在咨询后获得了最感兴趣的方法,3040名中的2382名(78%)将护理评为优秀或非常好。

关键数值与推荐

  • 所有提供者完成了1天的避孕知识、咨询、启动和管理综合培训,包括长效可逆避孕方法的放置和取出。
  • 向未绝育的育龄女性免费提供可逆避孕方法(包括长效可逆避孕方法),通过提供者报销和CDCF支持的基础设施实现。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prevention of unintended pregnancy is a primary strategy to reduce adverse pregnancy and birth outcomes related to Zika virus infection. The Zika Contraception Access Network (Z-CAN) aimed to build a network of health-care providers offering client-centred contraceptive counselling and the full range of reversible contraception at no cost to women in Puerto Rico who chose to prevent pregnancy during the 2016-17 Zika virus outbreak. Here, we describe the Z-CAN programme design, implementation activities, and baseline characteristics of the first 21 124 participants. METHODS: Z-CAN was developed by establishing partnerships between federal agencies, territorial health agencies, private corporations, and domestic philanthropic and non-profit organisations in the continental USA and Puerto Rico. Private donations to the National Foundation for the Centers for Disease Control and Prevention (CDCF) secured a supply of reversible contraceptive methods (including long-acting reversible contraception), made available to non-sterilised women of reproductive age at no cost through provider reimbursements and infrastructure supported by the CDCF. To build capacity in contraception service provision, doctors and clinic staff from all public health regions and nearly all municipalities in Puerto Rico were recruited into the programme. All providers completed 1 day of comprehensive training in contraception knowledge, counselling, and initiation and management, including the insertion and removal of long-acting reversible contraceptives (LARCs). Z-CAN was announced through health-care providers, word of mouth, and a health education campaign. Descriptive characteristics of programme providers and participants were recorded, and we estimated the factors associated with choosing and receiving a LARC method. As part of a Z-CAN programme monitoring plan, participants were invited to complete a patient satisfaction survey about whether they had obtained free, same-day access to their chosen contraceptive method after receiving comprehensive counselling, their perception of the quality of care they had received, and their satisfaction with their chosen method and services. FINDINGS: Between May 4, 2016, and Aug 15, 2017, 153 providers in the Z-CAN programme provided services to 21 124 women. 20 110 (95%) women received same-day provision of a reversible contraceptive method. Whereas only 767 (4%) women had used a LARC method before Z-CAN, 14 259 (68%) chose and received a LARC method at their initial visit. Of the women who received a LARC method, 10 808 (76%) women had used no method or a least effective method of contraception (ie, condoms or withdrawal) before their Z-CAN visit. Of the 3489 women who participated in a patient satisfaction survey, 3068 (93%) of 3294 women were very satisfied with the services received, and 3216 (93%) of 3478 women reported receiving the method that they were most interested in after receiving counselling. 2382 (78%) of 3040 women rated their care as excellent or very good. INTERPRETATION: Z-CAN was designed as a short-term response for rapid implementation of reversible contraceptive services in a complex emergency setting in Puerto Rico and has served more than 21 000 women. This model could be replicated or adapted as part of future emergency preparedness and response efforts. FUNDING: National Foundation for the Centers for Disease Control and Prevention.

来源:Lancet Public Health,查看原文。版权归原作者所有。

引用

  1. Lathrop E, Romero L, Hurst S, et al. The Zika Contraception Access Network: a feasibility programme to increase access to contraception in Puerto Rico during the 2016-17 Zika virus outbreak. Lancet Public Health. 2018. PMID: 29371100. doi:10.1016/S2468-2667(18)30001-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。